Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

NCT02164864 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2725

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Percutaneous Coronary Intervention

Interventions

DRUG: Dabigatran Etexilate 110mg
DRUG: Warfarin 3mg
DRUG: Aspirin
DRUG: Dabigatran Etexilate 150mg
DRUG: Clopidogrel or Ticagrelor
DRUG: Clopidogrel or Ticagrelor
DRUG: Warfarin 5mg
DRUG: Clopidogrel or Ticagrelor
DRUG: Warfarin 1mg

Sponsor

Boehringer Ingelheim